Hjem › Ulcerøs colitis › Georgia
Ulcerøs colitis kliniske forsøg i Georgia
14 studier for Ulcerøs colitis søger deltagere på steder i Georgia.
Byer i Georgia
Officiel studietekst (engelsk)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastroenterology Associates of Central Georgia /ID# 280464, Macon
- Gastroenterology Consultants - Roswell /ID# 281235, Roswell
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Digestive Healthcare of Georgia, Atlanta
- AGA GA Research LLC, Atlanta
RekruttererFase 4
Alder 18 til 80 · Alle køn · Opdateret 30. sep. 2026 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Childrens Center For Digestive Health Care /ID# 273228, Atlanta
RekruttererFase 3
Alder 2 til 17 · Alle køn · Opdateret 30. sep. 2026 · NCT07071519A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Gastroenterology Associates of Central Georgia ( Site 1060), Macon
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 28. sep. 2026 · NCT07463183A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Atlanta Gastroenterology Associates, Atlanta
- Children's Center for Digestive Health Care, Atlanta
- Gastroenterolgy Associates of Central GA, Macon
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07196748A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Emory University, Atlanta
- Children's Center for Digestive Healthcare, Atlanta
RekruttererFase 3
Alder 3 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06663332A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Atlanta Gastroenterology Associates - Peachtree Dunwoody, Atlanta
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Emory University School of Medicine, Atlanta
- Children's Center for Digestive Health Care, LLC, Atlanta
RekruttererFase 3
Alder 2 til 19 · Alle køn · Opdateret 22. sep. 2026 · NCT04844606A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Gastroenterology Consultants, P.C., Roswell
RekruttererFase 4
Alder 18 til 65 · Alle køn · Opdateret 21. sep. 2026 · NCT06095128Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Gastroenterology Consultants, P.C., Roswell
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 21. sep. 2026 · NCT07513181A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Atlanta Gastroenterology Specialists, Suwanee
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. aug. 2026 · NCT07577856An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Atlanta Gastroenterology Associates - Site Number: 8400109, Atlanta
- M3 Wake Research - Atlanta - Site Number: 8400028, Sandy Springs
- EBGS Clinical Research Center, LLC - Site Number: 8400037, Snellville
- og 1 flere
RekruttererFase 3
Alder 16 til 80 · Alle køn · Opdateret 20. aug. 2026 · NCT07184996A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Childrens Center For Digestive Healthcare, Atlanta
RekruttererFase 3
Alder 2 og opefter · Alle køn · Opdateret 7. maj 2026 · NCT05442567A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Atlanta
- Mirador Therapeutics Selected Site, Snellville
RekruttererFase 2
Alder 18 til 80 · Alle køn · Opdateret 12. mar. 2026 · NCT07113522Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.